Biotech Derivatives Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Derivatives

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (543)	9/19/2002 5:02:53 PM
From: keokalani'nui	Read Replies (1) of 555

Pacific Exchange to Trade Options on iShares Nasdaq Biotechnology Index Fund SAN FRANCISCO, June 24 /PRNewswire/ -- The Pacific Exchange (PCX) has announced that, on Tuesday, June 25, 2002, it will begin trading options on the iShares Nasdaq Biotechnology Index Fund (Amex: IBB; PCX). The fund is designed to correspond to the price and yield performance of the Nasdaq Biotechnology Index. IBB options will trade on the March expiration cycle. Position and exercise limits have been set at 13,500 contracts. The issue has been allocated to lead market maker Todd Kramer of Knight Financial Products. SOURCE: The Pacific Exchange

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next